|
|
|
|
Integrated Analysis of Emergent Drug Resistance Through 48 Weeks from Clinical Studies of HIV-1 Treatment-Naive Subjects Receiving E/C/F/TAF
|
|
|
Reported by Jules Levin
EACS 2015 Oct 21-25 Barcelona, Spain
MD Miller, N Margot, KM Kitrinos, M Fordyce, S McCallister, and C Callebaut
Gilead Sciences, Inc., Foster City, CA, USA
|
|
|
|
|
|
|